1,946
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Increased intestinal permeability and downregulation of absorptive ion transporters Nhe3, Dra, and Sglt1 contribute to diarrhea during Clostridioides difficile infection

, , , , , , , , & show all
Article: 2225841 | Received 09 Dec 2022, Accepted 09 Jun 2023, Published online: 23 Jun 2023
 

ABSTRACT

Background & Aim

Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea and pseudomembranous colitis. Two protein toxins, TcdA and TcdB, produced by C. difficile are the major determinants of disease. However, the pathophysiological causes of diarrhea during CDI are not well understood. Here, we investigated the effects of C. difficile toxins on paracellular permeability and apical ion transporters in the context of an acute physiological infection.

Methods

We studied intestinal permeability and apical membrane transporters in female C57BL/6J mice. Üssing chambers were used to measure paracellular permeability and ion transporter function across the intestinal tract. Infected intestinal tissues were analyzed by immunofluorescence microscopy and RNA-sequencing to uncover mechanisms of transporter dysregulation.

Results

Intestinal permeability was increased through the size-selective leak pathway in vivo during acute CDI in a 2-day-post infection model. Chloride secretory activity was reduced in the cecum and distal colon during infection by decreased CaCC and CFTR function, respectively. SGLT1 activity was significantly reduced in the cecum and colon, accompanied by ablated SGLT1 expression in colonocytes and increased luminal glucose concentrations. SGLT1 and DRA expression was ablated by either TcdA or TcdB during acute infection, but NHE3 was decreased in a TcdB-dependent manner. The localization of key proteins that link filamentous actin to the ion transporters in the apical plasma membrane was unchanged. However, Sglt1, Nhe3, and Dra were drastically reduced at the transcript level, implicating downregulation of ion transporters in the mechanism of diarrhea during CDI.

Conclusions

CDI increases intestinal permeability and decreases apical abundance of NHE3, SGLT1, and DRA. This combination likely leads to dysfunctional water and solute absorption in the large bowel, causing osmotic diarrhea. These findings provide insights into the pathophysiological mechanisms underlying diarrhea and may open novel avenues for attenuating CDI-associated diarrhea.

GRAPHICAL ABSTRACT

Abbreviations

CDI=

Clostridioides difficile infection

GI=

gastrointestinal

NHE3=

Na+/H+ Exchanger 3

DRA=

Downregulated in Adenoma

BHIS=

brain-heart infusion-supplemented medium

TA=

taurocholic acid

TCCFA=

taurocholic acid, D-cycloserine, cefoxitin and fructose agar

FITC=

fluorescein isothiocyanate

FD4=

4 kDa FITC dextran

RD70=

70 kDa rhodamine B dextran

KRB=

Krebs-Ringer Buffer

Isc=

short-circuit current

Rt=

transmucosal resistance

Gt=

tissue conductance

SGLT1=

sodium-dependent glucose cotransporter 1

ENaC=

epithelial sodium channel

CFTR=

cystic fibrosis transmembrane conductance regulator

PFA=

paraformaldehyde

NBF=

neutral buffered formalin

FFPE=

formalin-fixed paraffin embedded

OCT=

optimal cutting temperature embedding medium

ERM=

Ezrin/Radixin/Moesin

NHERF=

Na+/H+ exchanger regulatory factor

BI/NAP1/PCR-RT=

restriction endonuclease analysis type B1, North American pulse-field gel electrophoresis type 1, polymerase chain reaction ribotype

qRT-PCR=

quantitative real time-polymerase chain reaction

Acknowledgments

Thank you to the members of the Lacy lab for stimulating discussions and feedback on this manuscript. Thank you to Miguel Beristain, Greg Gomez, and Lee Brackman for technical assistance with qRT-PCR. Thank you to Kari Seedle and the Vanderbilt Cell Imaging Shared Resource Core for support on imaging and analyses; Vanderbilt Technologies for Advanced Genomics for support with RNA-sequencing; TPSR for histology support; and to Colin Kruse for advice on RNA-sequencing data analyses. The graphical abstract and cartoons in figures were made using BioRender.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Author contributions

Conceptualization, F.C.P.G., I.K., and D.B.L.; Methodology, F.C.P.G., I.K., A.S., J.A.S., and H.M.S.A.; Investigation, F.C.P.G., I.K., A.S., L.M.W., J.A.S., and M.K.W.; Writing – Original Draft, F.C.P.G.; Writing – Reviewing & Editing: I.K., A.S., H.M.S.A, P.K.D., J.R.G., and D.B.L.; Funding Acquisition, F.C.P.G., I.K., H.M.S.A, and D.B.L.; Resources, I.K., L.M.W., H.M.S.A., P.K.D, J.R.G., and D.B.L.; Supervision, I.K. and D.B.L.

Data availability statement

Large datasets (RNA-seq) are available online on Gene Expression Omnibus with identifier GSE216919. Reagents used in this study are either commercially available or available upon request.

Synopsis

Clostridioides difficile infection (CDI) causes increased intestinal fluid leakage and decreases the colon’s ability to absorb water and electrolytes. Using a mouse model of CDI, we found that intestinal permeability is increased through a size-selective pathway, and key absorptive ion transporters Sglt1, Nhe3, and Dra are downregulated. These factors likely cause diarrhea associated with CDI.

Transcript profiling

RNA-seq data were uploaded into GEO database (GSE216919).

Supplementary material

Supplemental data for this article can be accessed online at https://doi.org/10.1080/19490976.2023.2225841

Additional information

Funding

This work was supported by the National Institutes of Health (NIH) and the United States Department of Veterans Affairs (VA). Christopher Peritore-Galve was supported by NIH grant T32 DK007673 and a VI4 Mini-Sabbatical Fellowship and D. Borden Lacy received funding through NIH grant AI957555 and VA grant BX002943. Izumi Kaji received funding through NIH R01 DK128190 and the American Physiological Society John F. Perkins, Jr. Research Career Enhancement Award. Holly Algood was supported by VA Merit review BX000915 and a VI4 Mini-Sabbatical Fellowship. James Goldenring was supported by NIH R01 DK48370 and VA Merit Review 1I01BX000930. Pradeep Dudeja received funding through VA Merit Award BX002011, VA Senior Research Career Scientist Award 1IK6BX005242, and NIH NIDDK grant DK92441.